Marker Therapeutics, Inc. (MRKR)

2.27 +0.08 (+3.65%) USD  |  NASDAQ  |  Jan 22, 09:32
More

Marker Therapeutics Net Income (Quarterly)

Net Income (Quarterly) Chart

View Net Income (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade